ReviewHeliyon2022
Review in Heliyon, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Bimetallic nanoparticles as pioneering eco-friendly catalysts for remediation of pharmaceuticals and personal care products (PPCPs).Nanoscale advances · 2025Review
- Transformation of CuMaterials (Basel, Switzerland) · 2024Article
- Catalytic dechlorination of 1,2-DCA in nano CuScientific reports · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over the past decade, the nano zerovalent copper has emerged as an effective nano-catalyst for the environment remediation processes due to its ease of synthesis, low cost, controllable particle size and high reactivity despite its release during the remediation process and related concentration dependent toxicities. However, the improvised techniques involving the use of supports or immobilizer for the synthesis of Cu
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.